Sederende medicatie bij de geriatrische intensivecarepatient

Translated title of the contribution: Sedative drugs in the geriatric intensive care patient
  • Bart G. J. Dekkers
  • , Bert Loef
  • , Marijn Boer
  • , Ithamar Brinkman*
  • *Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    187 Downloads (Pure)

    Abstract

    The number of elderly patients admitted to Intensive Care Units (ICUs) has increased significantly in recent years. It has been demonstrated that the elderly are more prone to inadequate drug treatment and adverse drug effects. OBJECTIVE To perform a literature review on the effects of aging on pharmacokinetic and pharmacodynamic properties of commonly used sedative drugs in Dutch ICUs. DESIGN AND METHODS Literature review using PubMed. RESULTS Literature on the effects of aging on the pharmacology of commonly used sedative drugs in the ICU is scarce. For the general population, we found that for midazolam, propofol, fentanyl and remifentanil aging is associated with an increased susceptibility of the patients for the pharmaco-dynamic properties of these agents. This effect is confirmed for some of these drugs in ICU patients. In addition, a reduction in drug clearance was observed for propofol and remifentanil. CONCLUSION Based on these findings, we suggest to start with lower dosages for midazolam, propofol, fentanyl and remifentanil in elderly ICU patients and to re-evaluate frequently and adjust the therapy by clinical effect if necessary.

    Translated title of the contributionSedative drugs in the geriatric intensive care patient
    Original languageDutch
    Pages (from-to)25-29
    Number of pages5
    JournalPharmaceutisch Weekblad
    Volume152
    Issue number50
    Publication statusPublished - 15-Dec-2017

    Fingerprint

    Dive into the research topics of 'Sedative drugs in the geriatric intensive care patient'. Together they form a unique fingerprint.

    Cite this